Wave Life Sciences
WVE
78 hedge funds and large institutions have $936M invested in Wave Life Sciences in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 20 reducing their positions, and 12 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 20
0.5% less ownership
Funds ownership: 84.54% → 84.04% (-0.5%)
1% less capital invested
Capital invested by funds: $949M → $936M (-$13.1M)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 79 → 78 (-1)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$15.2M |
| 2 |
BlackRock
New York
|
+$14M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.2M |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$10.4M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$45M |
| 2 |
PA
Perceptive Advisors
New York
|
-$7.75M |
| 3 |
DM
Deerfield Management
New York
|
-$3.85M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.28M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.78M |
WVE Hedge Fund Activity: Q2 2018 in Review
78 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2018, worth a combined $936M — down 1.4% from $949M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of WVE and 11 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 40 added.
The largest buyer was Wells Fargo, adding an estimated $15.2M. The largest seller was EcoR1 Capital, cutting an estimated $45M.
- 78 institutional investors held Wave Life Sciences (WVE) as of Q2 2018, down from 79 in Q1 2018.
- Funds reported $936M of Wave Life Sciences stock for Q2 2018, down 1.4% quarter-over-quarter.
- 11 funds opened new Wave Life Sciences positions in Q2 2018 and 12 closed out, a net change of -1 holder.
- The largest Wave Life Sciences buyer in Q2 2018 was Wells Fargo, an estimated $15.2M added.
- The largest Wave Life Sciences seller in Q2 2018 was EcoR1 Capital, an estimated $45M sold.
Based on aggregated 13F filings for Q2 2018.